Kashaf Waqar and Zainab, A. (2022) “The tale and trials of Efgartigimod: a newly FDA approved drug for the treatment of Myasthenia gravis”, Journal of the Pakistan Medical Association, 72(11), pp. 2366–2367. doi: 10.47391/JPMA.6388.